MSCI: Staying Buy Rated As Fundamentals Have Improved While Valuation Derated

An analyst maintains a Buy rating on MSCI, citing a recovery in client demand across various sectors, including hedge funds and asset managers, driven by new private asset solutions and expansion into active ETFs. The analyst highlights an improved valuation at 32x forward PE, coupled with visible EPS growth catalysts, projecting a potential 20% upside to $672 per share despite broader market risks.

Analysis

MSCI is demonstrating a robust recovery in client demand, with growth observed across a diverse client base including hedge funds, banks, wealth managers, and asset owners. This resurgence is underpinned by several key growth drivers, notably the introduction of new private asset solutions, increased international fund flows, and strategic expansion into the active ETF market, further bolstered by a partnership with Moody's. From a valuation perspective, MSCI's forward price-to-earnings ratio has derated to a more attractive 32x. This improved valuation, combined with clearly identifiable catalysts for earnings per share (EPS) growth, supports a projected potential upside of 20% to a share price of $672. The reiterated buy rating reflects confidence in MSCI's growth trajectory, attributed to multiple tailwinds and strengthening fundamentals, despite prevailing market risks.

Key Decisions for Investors

• Investors should consider the current 32x forward P/E valuation as a potentially attractive entry point, given the identified EPS growth catalysts and a projected 20% upside to $672 per share.
• Monitor the execution and market adoption of MSCI's new private asset solutions and its expansion into active ETFs, as these are highlighted as key drivers for future growth.
• Factor in the broad-based client demand recovery and the strategic implications of the Moody's partnership when assessing MSCI's ability to navigate broader market risks and sustain its growth momentum.